fludarabine has been researched along with Sjogren's Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergier, G; Glass, F; McCardle, T; Moscinski, L; Naghashpour, M; Setoodeh, R; Sokol, L | 1 |
Enzenauer, RJ; Judson, PH | 1 |
2 other study(ies) available for fludarabine and Sjogren's Syndrome
Article | Year |
---|---|
Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Eyelids; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrobiotic Xanthogranuloma; Paraproteinemias; Rituximab; Sjogren's Syndrome; Treatment Outcome; Vidarabine | 2011 |
Type II mixed cryoglobulinemia treated with fludarabine.
Topics: Antineoplastic Agents; Cryoglobulinemia; Humans; Male; Middle Aged; Remission Induction; Sjogren's Syndrome; Vidarabine | 1996 |